Achillion Pharmaceuticals will present a corporate overview at three upcoming investor conferences in New York City and Chicago … more

Alexion Pharmaceuticals will presents at conferences in California and Chicago … more

Separately, Alexion reports that the European Commission has granted orphan drug status to ALXN1210, a C5 antibody being evaluated in patients with paroxysmal nocturnal hemoglobinuria … more